title: BPH update: medical versus interventional management.
abstract: Benign prostatic hyperplasia (BPH) is a common condition that afflicts a large proportion of aging men. The primary care physician has an important role with the identification and early treatment of bothersome urinary symptoms caused by BPH. This includes a detailed history and physical exam, as well as initiation of a number of medications such as alpha-blockers, 5-alpha reductase inhibitors and phosphodiesterase-5 inhibitors. It is also very important for the primary care giver to determine when additional evaluation and referral to a urologist needs to occur, specifically when surgical intervention is needed. This review will summarize the management of this common disorder and is designed to aid the generalist with the pertinent information needed to provide excellent care.
authors.affiliation: Department of Urology, McMaster University, Hamilton, Ontario, Canada.
authors.forename: Udi
authors.initials: U
authors.lastname: Blankstein
authors.forename: Brandon
authors.initials: B
authors.lastname: Van Asseldonk
authors.forename: Dean S
authors.initials: DS
authors.lastname: Elterman
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000072700:Conservative Treatment; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D053448:Prostatism / Q000209:etiology; D020728:Transurethral Resection of Prostate
chemical_list: D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D058986:Phosphodiesterase 5 Inhibitors